4.8 Article

Three-Dimensional Paper-Based Microfluidic Analytical Devices Integrated with a Plasma Separation Membrane for the Detection of Biomarkers in Whole Blood

Journal

ACS APPLIED MATERIALS & INTERFACES
Volume 11, Issue 40, Pages 36428-36434

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsami.9b13644

Keywords

3D paper-based microfluidic analytical devices; 3D printing plasma separation membrane; parylene C; glucose detection

Funding

  1. BioNano Health-Guard Research Center as Global Frontier Project [H-GUARD-2018M3A6B2057299]
  2. NRF - Ministry of Science and ICT (MSIT) of Korea [2018R1A2B2002066]
  3. National Research Foundation of Korea [2018R1A2B2002066] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Paper-based microfluidic analytical devices (mu PADs) have recently attracted attention as a point-of-care test kit because of their low cost and nonrequirement for external forces. To directly detect biomarkers in whole blood, however, they need to be assembled with a filter such as a plasma separation membrane (PSM) because the color of the blood cells interferes with the colorimetric assay. However, this assembly process is rather complicated and cumbersome, and the fluid does not uniformly move to the detection zone when the adhesion between the paper and PSM is not perfect. In this study, we report a simple three-dimensional (3D) printing method for fabricating PSM-integrated 3D-mu PADs made of plastics without the need for additional assembly. In detail, PSM was coated with parylene C to prevent its dissolution from organic solvent during 3D printing. Then, the coated PSM was superimposed on the paper. Detection zones and a reservoir were printed on the paper and PSM via liquid photopolymerization, using a digital light processing printer. The limit of detection of the PSM-integrated 3D-mu PADs for glucose in whole blood was 0.3 mM, and these devices demonstrated clinically relevant performance on diabetes patient blood samples. Our 3D-mu PADs can also simultaneously detect multiple metabolic disease markers including glucose, cholesterol, and triglycerides in whole blood. Our results suggest that our printing method is useful for fabricating 3D-mu PADs integrated with PSM for the direct detection of biomarkers in whole blood.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available